Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Revolution Medicines, Inc.(RVMD) | 7,601,087 | 7,601,087 | 0 | $739.21M | $1.42B | 67.55% | +$684.33M |
| Parabilis Medicines Inc | 0 | 4,663,176 | +4,663,176 | $0 | $127.63M | 6.06% | +$127.63M |
| Relay Therapeutics, Inc.(RLAY) | 5,526,506 | 6,776,506 | +1,250,000 | $54.99M | $126.79M | 6.02% | +$71.80M |
| Tyra Biosciences, Inc.(TYRA) | 4,055,861 | 3,553,585 | -502,276 | $155.34M | $113.50M | 5.39% | -$41.84M |
| Alumis Inc | 3,540,998 | 3,540,998 | 0 | $78.01M | $99.64M | 4.73% | +$21.64M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 7,162,637 | 7,162,637 | 0 | $90.75M | $77.57M | 3.68% | -$13.18M |
| Kymera Therapeutics, Inc.(KYMR) | 278,896 | 278,896 | 0 | $23.23M | $31.98M | 1.52% | +$8.75M |
| Zymeworks Inc.(ZYME) | 1,113,946 | 1,113,946 | 0 | $27.89M | $29.12M | 1.38% | +$1.23M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 304,237 | 761,153 | +456,916 | $5.00M | $18.42M | 0.87% | +$13.42M |
| Arvinas, Inc.(ARVN) | 539,394 | 1,122,713 | +583,319 | $5.72M | $17.12M | 0.81% | +$11.40M |
| CytomX Therapeutics, Inc.(CTMX) | 4,449,932 | 4,449,932 | 0 | $20.91M | $16.69M | 0.79% | -$4.23M |
| Silence Therapeutics plcADS(SLN) | 952,400 | 952,400 | 0 | $5.02M | $10.46M | 0.50% | +$5.44M |
| Corvus Pharmaceuticals, Inc.(CRVS) | 450,000 | 450,000 | 0 | $6.58M | $6.72M | 0.32% | +$139.5K |
| Context Therapeutics Inc.(CNTX) | 7,419,355 | 7,419,355 | 0 | $19.44M | $4.11M | 0.20% | -$15.33M |
| enGene Therapeutics Inc.(ENGN) | 0 | 2,324,943 | +2,324,943 | $0 | $4.02M | 0.19% | +$4.02M |
| ARS Pharmaceuticals, Inc.(SPRY) | 610,703 | 0 | -610,703 | $4.90M | $0 | — | -$4.90M |
| Cullinan Therapeutics, Inc.(CGEM) | 1,141,145 | 0 | -1,141,145 | $16.22M | $0 | — | -$16.22M |
| Engene Holdings Inc COM | 2,324,943 | 0 | -2,324,943 | $15.83M | $0 | — | -$15.83M |
| Tango Therapeutics, Inc.(TNGX) | 7,266,081 | 0 | -7,266,081 | $152.01M | $0 | — | -$152.01M |